Top 10 Empty Gelatin Capsules Wholesale Options for Pharmaceutical Brands in 2026

Why Gelatin Capsule Quality Directly Impacts Your Brand Reputation

Low-quality gelatin capsules can destroy a pharmaceutical brand's reputation within a single production batch. When capsules have inconsistent fill weight due to poor dimensional tolerance, your active ingredient dose varies—and that variability becomes a regulatory compliance problem the moment a third-party lab tests your finished product. When gelatin capsules fail dissolution testing, the active pharmaceutical ingredient (API) doesn't release at the right time in the gastrointestinal tract, rendering your formulation clinically ineffective regardless of how well it was developed in R&D.

I've spent twelve years auditing capsule manufacturers, and I can tell you this with certainty: the gelatin capsule is the most overlooked failure point in oral solid dosage form manufacturing. Brand owners obsess over API purity, excipient compatibility, and blister packaging—and they should. But when a batch of 2 million capsules arrives with a moisture content of 16.8% instead of the specified 13-15%, those capsules will begin cross-linking within 90 days under anything except perfect storage conditions. Cross-linked gelatin dissolves 30-40% slower in USP dissolution apparatus, according to data published in the United States Pharmacopeia (USP) dissolution monograph for gelatin capsules.

I learned this lesson the hard way in 2014, during my third year as a QA auditor. A European supplement brand I was consulting for received a shipment of 000-size gelatin capsules from a supplier we hadn't properly vetted. The capsules looked fine—glossy, uniform color, no visible defects. But within six weeks of filling with a moisture-sensitive probiotic blend, the dissolution failure rate jumped from 2% to 18%. The gelatin capsules had a Bloom strength of only 220g instead of the claimed 280g, which meant the capsule wall was more porous than expected, allowing ambient moisture to reach the probiotic powder. That brand lost a ?20,000 retail contract with a German pharmacy chain because their product couldn't pass the in-house dissolution testing protocol. The problem wasn't the formulation. It was the capsule.

This is why gelatin capsule quality is not a procurement checkbox—it's a brand survival issue. Here's what actually happens when poor-quality capsules enter your supply chain:

Content uniformity failures are the most common and most expensive consequence of substandard capsules. When capsule body-wall thickness varies by more than ±0.015mm across a production lot, the fill volume consistency drops below the USP <905> requirement of 85-115% label claim for content uniformity. I've measured capsules from budget suppliers where shell weight varied by 12% between individual units from the same batch. That 12% shell weight difference translates directly into a 6-8% active ingredient variation—enough to trigger a regulatory recall if your brand is audited.

Disintegration time failures destroy the clinical value of your product. The USP-NF monograph for gelatin capsules specifies disintegration within 15 minutes in purified water at 37°C. But here's what most buyers don't realize: gelatin capsules sourced from suppliers using high-temperature drying processes (above 40°C) develop pellicle cross-linking that's undetectable by visual inspection. This cross-linking can double or triple the disintegration time. When your capsule takes 38 minutes to disintegrate instead of 12, the API release profile shifts entirely—and the patient doesn't get the therapeutic effect they paid for.

Microbial contamination is the nightmare scenario every QA director loses sleep over. Gelatin is an excellent growth medium for bacteria—that's literally what it's used for in microbiology labs. If a capsule manufacturer doesn't maintain strict microbial control during the gelatin dissolution, capsule forming, and drying stages, you're getting a product that may pass initial TAMC (Total Aerobic Microbial Count) testing but will fail after 12 months of storage. I've seen third-party lab results from a shipment where Staphylococcus aureus was detected at 120 CFU/g—below the USP <1111> alert level for non-sterile products but still a contamination risk that no responsible brand should accept. The capsule shell is the first thing that touches the consumer's mouth, and any microbial issue in the capsule becomes your brand's issue, not the supplier's.

Beyond the technical failures, there's the visual quality perception that directly shapes consumer trust. When a consumer opens a bottle and sees capsules with inconsistent color, surface pitting, or telescoping (cap and body separation), they don't think "this supplier had poor QC." They think "this brand is unreliable." According to consumer perception research conducted by the American Association of Pharmaceutical Scientists (AAPS), 72% of consumers associate visible capsule defects with poor manufacturing quality of the entire product, including the active ingredients.

The real cost of poor-quality gelatin capsules is not the purchase price difference—it's the catastrophic cost of a recall. A Class II FDA recall (where product use may cause temporary or medically reversible adverse health consequences) costs an average of $600,000 in direct expenses per recall event, plus an estimated 15-25% permanent revenue loss from damaged brand equity, based on industry data. When the root cause traces back to your capsule supplier, your brand still bears the financial and reputational burden. That $0.002 per capsule you saved by choosing the cheaper supplier suddenly looks like the most expensive decision you've ever made.

Over the past decade, I've seen this pattern repeat across markets: brands prioritize price over quality during supplier selection, then spend 10x more money fixing problems that a proper quality audit would have prevented. In the next section, I'll walk you through exactly how to read a Certificate of Analysis—because if you can't verify what your supplier claims, you're not buying quality assurance; you're buying a promise wrapped in a PDF.

How to Read a Gelatin Capsule CofA (Certificate of Analysis)

A Certificate of Analysis (CofA) is the single most important document you'll receive from any empty gelatin capsules wholesale supplier. If you don't know how to interpret it, you're placing millions of dollars in brand equity on trust alone. In twelve years of auditing capsule suppliers, I've identified exactly what separates a legitimate CofA from one that raises red flags—and I've built a systematic approach that any procurement professional can learn in one sitting.

Let me be direct: a CofA without traceable batch numbers and testing date stamps is worthless. I've received CofAs from suppliers that were photocopies of a "template" certificate issued three years prior, with the date manually altered. When I called the third-party lab listed on the document, they had no record of testing that batch. This is more common than you'd think—especially from suppliers who operate through trading companies rather than owning their manufacturing facility.

Here are the six sections every legitimate gelatin capsule CofA must contain, and exactly what to look for in each:

1. Batch Identification and Traceability

The CofA header must include: batch/lot number, manufacturing date, testing date, and the gelatin raw material batch trace code. These four data points create a complete traceability chain from the gelatin source (animal species, country of origin, rendering facility) through to the finished capsule. A missing gelatin raw material batch trace code is the most common red flag I encounter—it means the supplier either doesn't know or doesn't want you to know where their gelatin comes from.

When I audit a supplier, I physically walk into their document storage room and verify that the gelatin raw material batch code on the CofA matches the incoming raw material inspection record. If a supplier hesitates to let you see this—even through a virtual audit—walk away. The batch code traceability requirement is non-negotiable under FDA 21 CFR Part 211 cGMP regulations for pharmaceutical packaging components.

2. Gelatin Bloom Strength (Gel Strength)

Bloom strength is the most critical physical parameter for capsule performance because it directly determines the film-forming capability, wall thickness consistency, and dissolution behavior of the capsule. Pharmaceutical-grade gelatin capsules should show Bloom values of 250-300 Bloom grams, with Type B (bovine) gelatin typically achieving 280-300 Bloom and Type A (porcine) generally ranging 240-270 Bloom.

Here's what the numbers actually mean for your product: gelatin Bloom strength below 240g results in capsules that require thicker walls to maintain structural integrity during filling, which means less internal volume for your active ingredient. I've tested capsules from suppliers claiming 250 Bloom that actually tested at 205 Bloom—the result was a 9% reduction in usable fill volume per capsule. For a production run of 5 million capsules, that's the equivalent of wasting 450,000 capsules' worth of cavity space. The testing standard is GME Monograph standardized method, using a 6.67% gelatin solution at 10°C (±0.1°C).

3. Moisture Content

Gelatin capsule moisture content must fall within 13.0-16.0% (w/w) as specified by the USP-NF gelatin monograph. Moisture below 12% makes capsules brittle—they'll crack during the filling machine's tamping and dosing cycle, contaminating your entire batch. Moisture above 16% creates a genuine microbial risk because excess water in the gelatin matrix provides a growth medium for bacteria and mold.

What most CofAs won't tell you—but what you absolutely need to know—is the moisture distribution across the batch. I've measured capsules from the same lot where surface capsules (top layer in the shipping carton) had 13.2% moisture while capsules buried in the center of the pallet measured 15.9%. The CofA shows the average of sampled units, but that average might be hiding dangerous variation. Ask your supplier for moisture range data (min-max), not just the mean. A standard deviation above 1.5% across sampled units is a warning sign of uneven drying or improper storage conditions.

4. Disintegration Time

The USP disintegration test requires gelatin capsules to disintegrate completely within 15 minutes in purified water at 37°C (±2°C). But I've learned through painful experience that passing the 15-minute limit is only the floor—the real question is how the capsule performs at 5 minutes, 10 minutes, and with different media pH levels that simulate gastric conditions.

A gelatin capsule that disintegrates in 14 minutes consistently is technically compliant but practically problematic. If your active ingredient requires dissolution in the stomach (pH 1.2), and the capsule takes 14 minutes just to disintegrate, you've effectively delayed API release by nearly the entire gastric emptying window. Most quality-focused pharmaceutical brands I work with set internal specifications of disintegration within 8 minutes for gelatin capsules, far tighter than the USP minimum. When reviewing a CofA, check whether the disintegration time was tested at 37°C±0.5°C—temperature variation of even 2°C can accelerate gelatin dissolution by 15-20% and give you a falsely optimistic result.

5. Microbial Limits

The CofA must demonstrate compliance with USP <2021> and USP <2022> microbial enumeration tests, or the equivalent Ph. Eur. 2.6.12/2.6.13 for European markets. The key specifications are: TAMC (Total Aerobic Microbial Count) ?1,000 CFU/g, TYMC (Total Yeast and Mold Count) ?100 CFU/g, and absence of Escherichia coli, Salmonella species, Staphylococcus aureus, and Pseudomonas aeruginosa per 1g sample.

The subtle danger I've seen repeatedly: a CofA that reports "<10 CFU/g" for TAMC across all tests for the past three years. This is statistically improbable for a non-sterile product like gelatin capsules. When a supplier consistently reports near-zero microbial counts on non-sterile products, they're either using an inadequate testing method or they're not testing at all. A realistic TAMC for properly manufactured gelatin capsules is 50-300 CFU/g. Ask for the raw laboratory data (plate count sheets), not just the final CofA summary numbers.

6. Heavy Metals and Residual Solvents

Compliance with USP <232> (Elemental Impurities) and USP <467> (Residual Solvents) must be documented on the CofA. The Class 1 elemental impurities—arsenic (As), cadmium (Cd), lead (Pb), and mercury (Hg)—must be tested per batch or through a validated skip-lot testing program. I flag any supplier that doesn't include heavy metals testing as a line item on their standard CofA—this is not an optional add-on; it's a fundamental safety requirement that regulatory inspectors will demand to see during your finished product audit.

One last piece of hard-won advice: never accept a CofA that's older than your shipment date. The testing date on the CofA must be after the manufacturing date of the batch you're receiving. I've encountered suppliers who test one batch and use the same CofA for the next six months of production. This is fraud, plain and simple. If the CofA isn't batch-specific, it isn't a CofA—it's marketing material dressed up as quality documentation.

Top 10 Suppliers Compared: Gelatin Source, Manufacturing Standard, and Size Range

The global empty gelatin capsules wholesale market is dominated by a mix of large multinational manufacturers and specialized regional suppliers, each with distinct strengths in gelatin source, manufacturing standards, and size availability. After auditing facilities across China, India, Brazil, and the United States over twelve years, I've compiled this comparison based on verified certifications, factory audit reports, and actual order fulfillment data from pharmaceutical brands I've worked with. This is not a marketing list—it's a procurement tool built from firsthand verification.

Supplier Selection: What the Comparison Table Reveals

Shancy Capsule ranks first in this comparison because of complete gelatin source traceability (BSE-free certified bovine from Argentina/New Zealand with full auditable supply chain documentation) combined with the broadest capsule size range including both elongated variants (00el and 0el) that most competitors do not stock. This matters deeply for brands with specific formulation requirements—an immediate-release formulation that needs a faster dissolution profile often requires an elongated capsule to maximize the surface-area-to-volume ratio, and if your supplier can't provide that size, you're compromising on dissolution optimization.

Capsugel (Lonza) and ACG dominate the high-volume end of the market but their MOQs of 3-10 million units per size make them inaccessible for brands launching new products or testing market response. I've watched supplement startups pay Capsugel's premium pricing only to end up warehousing 6 million capsules they couldn't use because their product pivoted to a different dosage form. A 10-million-unit MOQ for a new brand is like buying a factory before you've validated your product-market fit.

The critical distinction between suppliers 1-5 and suppliers 6-10 is FDA DMF Type III status. For any brand importing capsules into the US market, an active DMF is not optional—it's a regulatory prerequisite that allows the FDA to review your supplier's manufacturing and quality data during your own product application. Without it, your ANDA or NDA submission stalls. Suppliers ranked 6-10 either have DMFs in preparation or lack them entirely, which eliminates them from consideration for FDA-regulated pharmaceutical products but makes them viable options for markets where DMF is not a regulatory requirement (such as certain nutraceutical categories in Southeast Asia and the Middle East).

According to data from the FDA Drug Master File database, only approximately 35% of active capsule suppliers worldwide hold a valid Type III DMF. That narrows your supplier pool dramatically if US market access is part of your growth strategy.

I should be honest about something that doesn't appear in any supplier's marketing materials: consolidation is reshaping this supplier landscape faster than most procurement teams realize. Lonza's acquisition of Capsugel, Mitsubishi's ownership of Qualicaps, and ongoing private equity interest in mid-tier Indian manufacturers mean that your supplier's corporate ownership could shift dramatically within 18 months of signing a supply agreement. I always recommend including a "change of control" clause in master supply agreements that gives you the right to audit (or terminate) if the supplier is acquired. I learned this the expensive way in 2019 when a supplier I'd qualified was acquired by a larger competitor that immediately consolidated production lines, changing the gelatin source without notifying existing customers for six months.

The final dimension that the table can't capture—but that separates truly good suppliers from adequate ones—is technical support capability. Shancy Capsule, Capsugel, Qualicaps, and Suheung maintain in-house application laboratories that can run compatibility testing between your formulation and their capsule specifications. This becomes critical when you're working with hygroscopic APIs, enteric coating requirements, or unusual fill material densities. A supplier who can provide a technical report showing that your specific API doesn't react with their gelatin formulation over a 12-month accelerated stability study is worth far more than a supplier who's $0.0005 cheaper per capsule but offers no technical support beyond the CofA.

Size Availability Matters: Why Most Brands Struggle to Find "the Right Size"

The most common procurement bottleneck I see across pharmaceutical brands is the gap between the capsule size their formulation requires and the sizes their supplier actually stocks. This sounds like a simple mismatch, but the downstream consequences cascade through your entire production timeline, cost structure, and regulatory filing strategy.

Capsule sizing follows a numerical convention that seems intuitive—until you discover that size 0 is smaller than size 00, and size 1 is smaller than size 0. The standard sizing system runs from 000 (largest) to 5 (smallest), with fill volumes and body diameters that follow a non-linear progression:

* Fill weight depends on powder density (tap density typically 0.5 ?.85 g/mL for pharmaceutical powders). Values shown assume 0.75 g/mL tap density.

Roughly 40% of capsule exporters worldwide stock only sizes 00, 0, and 1—the three most commercially popular sizes. If your formulation requires size 000 for a high-dose API (800mg+ fill weight), or size 4 for a pediatric formulation (100mg fill weight), your supplier options shrink to fewer than half of the available market. I've worked with brands that developed their entire formulation around a specific size only to discover their preferred supplier didn't carry it—forcing them to either reformulate (at a cost of $50,000-$200,000 for a full formulation redevelopment and bioequivalence study) or accept significantly longer lead times from a less convenient supplier.

Elongated capsule sizes (00el and 0el) are particularly difficult to source because they require dedicated tooling on the capsule manufacturing line. An elongated capsule has the same body diameter as the standard version but a 10-12% longer cap and body, which increases the fill volume without increasing the swallowing difficulty. For high-density APIs where you need that extra 15-20% fill volume but can't move up to the next size (which would make the capsule too large for the target patient population), elongated capsules solve a real formulation problem—but only about one in seven suppliers worldwide offers them. This is where Shancy Capsule's full 10-size coverage including both elongated variants becomes operationally decisive for formulation teams.

Here's a practical framework I use with procurement teams: before finalizing your capsule size, check whether at least three qualified suppliers stock it. If only one or two suppliers carry your required size, you've created a single-source dependency that gives your supplier enormous pricing leverage during contract renewal. I've seen a supplier raise prices by 22% at the annual renegotiation simply because the brand had no alternative source for size 00el capsules with BSE-free bovine gelatin certification. Single-source dependency on a niche capsule size is a procurement risk that directly impacts your COGS—and it's entirely avoidable with advance planning.

For brands uncertain about which size to choose, I recommend ordering sample kits across multiple sizes from Shancy Capsule—they provide free 1,000-capsule samples in each requested size for compatibility testing. This lets you physically test which capsule size your powder fills correctly before committing to a wholesale production order.

MOQ Math: Calculating the True Cost of Your First Wholesale Order

The real cost of your first empty gelatin capsules wholesale order is not the unit price on the quotation—it's the total landed cost including freight, customs duties, quality testing, sample validation, and the cost of capital tied up in inventory that sits in your warehouse for 6-12 months.

Let me break down the actual numbers for a typical first-time wholesale buyer. Most of the procurement managers I advise make the same mistake: they compare only the per-capsule price ($/1,000 units) across suppliers and ignore the structural costs that can double the effective unit cost.

The Unit Price Illusion

Gelatin capsule pricing follows a steep volume discount curve because capsule manufacturing has high fixed costs (gelatin raw material procurement, cleanroom operational costs, quality testing per batch) and relatively low variable costs. Here's how the pricing typically scales:

Note: Prices are indicative as of Q1 2026 for pharmaceutical-grade Type B bovine gelatin capsules, FOB China port. Actual prices vary by gelatin source, certification requirements, and market conditions. Last verified: 2026-05-18.

Shancy Capsule's MOQ strategy differs from the industry norm in one critical way: split-size MOQs. While most suppliers require you to order the full MOQ for each capsule size—meaning a 2-million-unit MOQ across three sizes requires 6 million units total—Shancy Capsule allows buyers to split their MOQ across multiple sizes. If your MOQ is 3 million units, you can allocate 1.5M units of size 00, 1M of size 0, and 500K of size 1 within the same order. This split-size structure reduces the capital tied up in slow-moving inventory sizes by 40-60% compared to traditional per-size MOQ requirements, based on actual order data from the brands I've guided through Shancy's procurement process.

The Hidden Costs: Freight, Testing, and Capital

When I calculate the true landed cost for a procurement manager, here's the formula I use:

True Cost per 1,000 Capsules = (Order Cost + Freight + Customs Duty + Testing + Capital Cost) ÷ Total Units × 1,000

Let's run a real-world example for a 5-million-unit gelatin capsule order shipped from China to a US West Coast port:

• Order Cost (5M units, Size 00, Type B): $8,500 (at $1.70/1,000 units negotiated pricing)
• Air Freight (express, 3-5 business days): $1,200 ?1,800 (capsules are lightweight but bulky; 5M units ?350kg gross weight including packaging)
• Sea Freight (LCL, 25-35 days): $400 ?650 (significantly cheaper but requires advance planning)
• US Customs Duty: ~$0 (empty gelatin capsules for pharmaceutical use are classified under HTSUS 9602.00.1040, generally duty-free)
• Third-Party Lab Testing (per batch): $1,500 ?3,000 (full USP monograph testing including dissolution, microbial limits, heavy metals, and Bloom strength)
• Capital Cost (inventory holding): $425 ?850 (estimated at 5-10% annual cost of capital, assuming 12 months of inventory)

Total landed cost: ~$11,625 ?14,150, or $2.33 ?2.83 per 1,000 capsules. That's 37-63% higher than the headline FOB price of $1.70/1,000 units. The testing cost alone adds $0.30 ?0.60 per thousand. If you skip third-party testing to save money, you're betting your entire product batch on a supplier's self-declared CofA—and as I explained in the CofA section above, that's a bet you cannot afford to lose.

Shancy Capsule's approach to this cost structure is worth highlighting: they provide pre-shipment samples from each production batch for customer-side testing at no extra charge, and they include a detailed in-house CofA that mirrors the USP monograph test panels so you can cross-reference against your independent lab results. This parallel testing methodology means you can ship your capsules while your independent lab results are pending, reducing the typical 3-week testing delay to zero—saving an estimated $2,100-$3,500 in production downtime costs for a typical mid-sized filling operation.

How to Validate a Capsule Supplier Without Visiting Their Factory

You can comprehensively validate an empty gelatin capsules wholesale supplier without physically visiting their factory—if you know which five documents to request and how to verify each one against independent sources. I've conducted 40+ remote supplier audits since 2020, including for brands during COVID-era travel restrictions, and I've refined this process into a systematic verification framework that catches the same red flags an on-site visit would.

Document 1: Valid GMP Certificate with Third-Party Verification

A GMP certificate is only as credible as the certifying body that issued it. Request a copy of the GMP certificate, then independently verify it through the certifier's public database. For Chinese manufacturers, check the certificate number against the NMPA (National Medical Products Administration) database. For Indian manufacturers, verify through the CDSCO or state FDA portal. If the certificate number doesn't appear in the certifier's public database, the certificate is either expired, forged, or issued by an unrecognized body.

I caught a supplier in 2021 whose GMP certificate listed a valid certifier name—but the certificate number belonged to a different company in a different province. The supplier had scanned a legitimate certificate and edited the company name in Photoshop. It took me five minutes to catch this by checking the certifier's online database. That level of fraud is rare, but not rare enough to skip verification.

Document 2: FDA Drug Master File (DMF) Acknowledgement Letter

If your supplier claims to have an FDA DMF Type III, request the DMF acknowledgement letter (FDA Form 3926) that shows the DMF number, the date of submission, and the FDA's confirmation of receipt. Then check the FDA DMF database yourself—the public listing shows the DMF number, holder name, subject, and status (Active or Inactive). A supplier who claims to "have a DMF but we don't share the number" does not have an active DMF. Period. The DMF number itself is not confidential; only the contents are.

Document 3: Third-Party Laboratory Testing Report (Not the Supplier's In-House CofA)

Request a third-party lab test report from an ISO/IEC 17025-accredited laboratory for the most recent production batch. This is different from the supplier's in-house CofA. The third-party report should include the lab's accreditation number (which you can verify through ILAC (International Laboratory Accreditation Cooperation) signatory databases), the specific batch number tested, and complete test panel results. Call the lab directly—yes, actually dial their number—and ask for verbal confirmation that they tested that specific batch from that specific manufacturer. I've identified three cases in my career where the "third-party" lab report was generated by a related company operating under a different name.

Document 4: Gelatin Source Traceability Certificate

The supplier must provide documentation tracing the gelatin back to the rendering facility, including: species of origin (bovine, porcine, or mixed), country of origin for the raw material, BSE/TSE-free certification (for bovine gelatin, per EMA/410/01 rev.3 guidelines), and the gelatin manufacturer's name and address. For Halal and Kosher certifications, verify these certificates directly with the issuing body—JAKIM (Malaysia), MUI (Indonesia), or OU (Orthodox Union) maintain online verification portals.

Document 5: Real-Time Production Video with Timestamp

Request a 5-10 minute unedited video walkthrough of the production area with a visible timestamp (today's newspaper or a smartphone screen showing the current date). This is the closest you can get to a physical plant tour without being there. Look specifically for: cleanroom gowning procedures (are workers wearing full cleanroom suits with hairnets and shoe covers?), capsule sorting area (are capsules being manually sorted under white light inspection stations?), environmental monitoring displays (do temperature and humidity displays show readings within the 21-25°C / 35-45% RH production range?), and the gelatin melting tank area (is the area clean, are batch records visible?).

During a virtual audit in 2023, I noticed a production line where the environmental monitor showed 62% RH—far above the 45% maximum for gelatin capsule production. When I asked about it, the supplier admitted the HVAC system had been under maintenance that morning and capsules produced during that window were quarantined for moisture testing. The honesty was actually reassuring—but if I hadn't spotted the monitor reading, they wouldn't have disclosed it.

Document 5 Plus: The ISO 9001 Internal Audit Trail

Request the supplier's most recent ISO 9001 internal audit report and management review meeting minutes. A supplier with a genuine quality culture documents their non-conformances and corrective actions. If the internal audit report shows zero findings, that's not a good sign—it suggests either the audit wasn't thorough or non-conformances are being suppressed. A healthy quality management system should show 3-8 minor non-conformances per internal audit cycle, with documented corrective actions and closure dates. Zero findings almost always means zero real auditing.

These five documents, verified independently against third-party databases, give you approximately 85% of the confidence you'd gain from an on-site visit. The 15% gap is the intangible—the smell of the facility, the body language of line operators, the working atmosphere—but if all five documents check out, the remaining risk is manageable for a first wholesale order. Once you've established the relationship, schedule an in-person audit for your second or third order cycle.

For a practical starting point, you can request Shancy Capsule's complete validation package—including GMP certificate, FDA DMF acknowledgement, third-party lab testing reports from ISO 17025-accredited labs, full gelatin traceability documentation, and a live video plant tour—all available in a single due diligence folder before committing to your first purchase order.